Early Dupilumab Response Predicts Pediatric Atopic Dermatitis Disease Relapse-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early Dupilumab Response Predicts Pediatric Atopic Dermatitis Disease Relapse

Published:2024-07-01 Issue: Volume: Page:
ISSN:1710-3568
Container-title:Dermatitis®
language:en
Short-container-title:Dermatitis®

Author:

Zhao Mutong¹^ORCID,Shen Chunping¹,Tian Jing¹,Li Xu²³^ORCID,Wang Shan¹,Liu Ying¹,Jiao Lei¹,Wang Yang¹,Sun Jing¹,Wu Qiong¹,Gu Ying¹,Yang Zhou¹,Wang Nan¹,Ma Lin¹,Liang Yuan¹

Affiliation:

1. Department of Dermatology, Beijing Children’s Hospital, Capital Medical University, National Key Discipline of Pediatrics, Key Laboratory of Major Diseases in Children, Ministry of Education, National Center for Children’s Health, Beijing, People’s Republic of China.

2. Department of Dermatology, The First Hospital of Hohhot, Hohhot, People’s Republic of China.

3. Department of Allergy, The First Hospital of Hohhot, Hohhot, People’s Republic of China.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/derm.2024.0160

Reference5 articles.

1. Atopic dermatitis

2. Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial

3. Dupilumab prevents flares in adults with moderate to severe atopic dermatitis in a 52-week randomized controlled phase 3 trial

4. Protocol for a prospective, observational, longitudinal study in paediatric patients with moderate-to-severe atopic dermatitis (PEDISTAD): study objectives, design and methodology

5. Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP